Alterity, UniQuest team up to reverse bacterial resistance to antibiotics

Alterity Therapeutics has announced it has been granted a licence by UniQuest, the commercialisation company of The ...

December 22, 2020 | Tuesday | News
Harbour BioMed licenses SARS-CoV-2 neutralizing Ab to AbbVie for COVID-19 treatment

China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...

December 22, 2020 | Tuesday | News
Sosei Heptares and GSK target immune disorders of digestive system

Japanese firm Sosei Group Corporation has announced that it has entered into a global collaboration and license agr...

December 21, 2020 | Monday | News
GenScript and InnoBation enter into agreement for CAR-T therapy

A global leading biotech company GenScript Biotech Corporation announces that it has reached the agreement for cell line...

December 18, 2020 | Friday | News
Australia, UK focus on respiratory complications in recovered Covid-19 patients

CN Bio, a leading cell culture company based in the UK, has announced a collaboration with the University of Melbourne i...

December 17, 2020 | Thursday | News
Alvotech and Fuji Pharma extend biosimilar partnership in Japan

Alvotech and Japanese pharmaceutical company Fuji Pharma have announced that they have agreed on an extension on their e...

December 16, 2020 | Wednesday | News
RoosterBio inks agreement with Sartorius Korea Biotech

RoosterBio, Inc, a leading supplier of innovative cellular therapy bioprocess tools and scalable manufacturing solutions...

December 7, 2020 | Monday | News
Singapore discovers role of protein in detecting common cold virus

The role of a protein in detecting the common cold virus and kickstarting an immune response to fight infection has been...

December 2, 2020 | Wednesday | News
Taiwan's AP Biosciences and LuminX develops novel cancer treatments

Taiwan's AP Biosciences and LuminX are accelerating the development of drugs and therapies for innovative cancer treatme...

December 1, 2020 | Tuesday | News
Singapore selectively targets pathogenic bacteria using lysins

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...

December 1, 2020 | Tuesday | News
Taiwan announces breakthrough in AML treatment

Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, announces that its new drug Antroquinonol (HO...

November 27, 2020 | Friday | News
Korea develops technology to reverse skin cell aging

Amorepacific R&D Center, together with the Korea Advanced Institute of Science & Technology (KAIST), developed a...

November 27, 2020 | Friday | News
Israel discovers antibody combo to fight COVID-19

Researchers at the Laboratory of Human Antibody Research at Tel Aviv University’s Sackler Faculty of Medicine have...

November 26, 2020 | Thursday | News
Pfizer, LianBio collaborate to bring novel therapeutics in Greater China

US-based Pfizer, Inc. and Shanghai-based LianBio have recently announced that they have entered into a collaboration aim...

November 20, 2020 | Friday | News
AUM, Newsoara Biopharma to co-develop next-gen cancer therapeutics

AUM Biosciences (AUM), a global, clinical-stage healthcare company based in Singapore, focused on discovering, acquiring...

November 20, 2020 | Friday | News
Taiwan discovers new gastric cancer biomarkers for tailored therapy

A research team led by Professor Wang Wen-ching of the Institute of Molecular and Cellular Biology, National Tsing Hua U...

November 17, 2020 | Tuesday | News
Singapore reveals novel method for cancer treatment

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singa...

November 16, 2020 | Monday | News
Australia evaluates hyperimmune immunoglobulin treatment for COVID-19

Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...

November 9, 2020 | Monday | News